Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2970)
  2. Department of Medicine (2970)
  3. Hematologic Malignancies, Division of (2847)
  4. Survivorship Research (1388)
  5. GSK Faculty (931)
  6. CTCR Scholars (873)

More Groups

People
  1. Sergio Giralt (1068)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (67)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2970)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Host-derived IL-22 protects intestinal stem cells from GVHD
    Meeting Abstract

    Hanash, A.; Dudakov, J.; Hua, G.; O'connor, M.; Jenq, R.; Holland, A.; Smith, O.; Liu, C.; Fouser, L.; Kolesnick, R.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • KIR3DL1/S1 and HLA-B alleles combine to influence unrelated hematopoietic stem cell transplantation (HSCT) outcomes
    Meeting Abstract

    Giglio, F.; Venstrom, J. M.; Gooley, T. A.; Gallagher, M. M.; Lebedeva, T.; Noreen, H.; Rajalingam, R.; Reed, E. F.; Vierra-Green, C.; Yu, N.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Trail over-expression on donor T cells enhances GVT and suppresses GVHD by inhibiting alloreactive T cells and impairing host APC functions
    Meeting Abstract

    Ghosh, A.; Dogan, Y.; Holland, A. M.; Young, L. F.; West, M. L.; Singer, N. V.; Smith, O. M.; Jenq, R. R.; Na, I. K.; Penack, O.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • "No wash" albumin-dextran dilution for double-unit cord blood transplantation (DCBT) is safe with appropriate management and results in high rates of sustained donor engraftment
    Meeting Abstract

    Dahi, P. B.; Lubin, M. N.; Evans, K. L.; Gonzales, A. M. R.; Schaible, A.; Tonon, J.; Heller, G.; Ponce, D. M.; Kernan, N. A.; Scaradavou, A.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Targeted Janus kinase-2 inhibition overcomes limitations of IL6-receptor-alpha blockade in controlling human DC-stimulated alloreactivity
    Meeting Abstract

    Betts, B. C.; Abdel-Wahab, O.; Curran, S. A.; St Angelo, E. T.; Koppikar, P.; Kennedy, M.; Heller, G.; Levine, R. L.; Young, J. W.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Double-unit cord blood transplantation (DCBT) for acute leukemia: High disease-free survival in adults and children with comparable survival in European and minority patients
    Meeting Abstract

    Barker, J. N.; Ponce, D. M.; Gonzales, A. M. R.; Lubin, M. N.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J. D.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Prognostic value of response after upfront therapy for acute GVHD
    Journal Article

    Saliba, R. M.; Couriel, D. R.; Giralt, S.; Rondon, G.; Okoroji, G. J.; Rashid, A.; Champlin, R. E.; Alousi, A. M.
    Bone Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor
    Journal Article

    Cheung, I. Y.; Hsu, K.; Cheung, N. K. V.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
    Journal Article

    Bashir, Q.; Shah, N.; Parmar, S.; Wei, W.; Rondon, G.; Weber, D. M.; Wang, M.; Orlowski, R. Z.; Thomas, S. K.; Shah, J.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save